Bidda Rolin - Concepedia

Author

Bidda Rolin

Also Known As

B Rolin, B. C. Rolin, B. Rolin, BIDDA ROLIN, Bidda Charlotte Rolin, Bidda Rolin, Dorthe Carlson, N. Irwin, Rolin B., Rolin, B.

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)University of Copenhagen Rigshospitalet Gubra (Denmark)Royal Agricultural University

About

Bidda Rolin is an author at Novo Nordisk (Denmark) specializing in medicine, diabetes, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	1.4K
2	Health Sciences	13	13	936
3	Natural Sciences	1	1	63
4	Public Health	1	1	55
5	Allergy	1	1	55

Bidda Rolin

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways Günaj Rakipovski, Bidda Rolin, Jane Nøhr, JACC Basic to Translational Science	2018	437
Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Jannie Fuhlendorff, Patrik Rorsman, Hans Kofod, Diabetes	1998	312
The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice Bidda Rolin, Marianne O. Larsen, C. F. Gotfredsen, American Journal of Physiology-Endocrinology and Metabolism Diabetic MiceFood IntakeInsulin SignalingGastrointestinal Peptide HormoneObesity	2002	280
Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not Kirsten Raun, Pia von Voss, C. F. Gotfredsen, Diabetes NutritionEnergy ExpenditureFood IntakeExperimental NutritionGastrointestinal Peptide Hormone	2006	204
GLP‐1 derivative liraglutide in rats with <i>β</i>‐cell deficiencies: influence of metabolic state on <i>β</i>‐cell mass dynamics Jeppe Sturis, C. F. Gotfredsen, John Rømer, British Journal of Pharmacology	2003	199
Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats Christian L. Brand, Bidda Rolin, Peer Nobert J�rgensen, Diabetologia Streptozotocin-diabetic RatsDiabetesBlood Glucose MonitoringMonoclonal Glucagon AntibodyDiabetes Mellitus	1994	137
Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes Marianne O. Larsen, Michael Wilken, C. F. Gotfredsen, American Journal of Physiology-Endocrinology and Metabolism Nonrodent ModelsMetabolic SyndromeInsulin DeliveryHealth SciencesDiabetes Management	2002	100
NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs Ulla Ribel, Marianne O. Larsen, Bidda Rolin, European Journal of Pharmacology Anti-diabetic EffectsBiochemistryG Protein-coupled ReceptorMedicineDiabetes	2002	77
Chamber-Dependent Expression of Brain Natriuretic Peptide and Its mRNA in Normal and Diabetic Pig Heart Christina Christoffersen, Jens P. Goetze, Emil D. Bartels, Hypertension Precursor Bnp MrnaCardiac MuscleChamber-dependent ExpressionBnp ExpressionCardiovascular Function	2002	63
Measurements of Insulin Secretory Capacity and Glucose Tolerance to Predict Pancreatic β-Cell Mass In Vivo in the Nicotinamide/Streptozotocin Gottingen Minipig, a Model of Moderate Insulin Deficiency and Diabetes Marianne O. Larsen, Bidda Rolin, Michael Wilken, Diabetes	2003	60

Page 1